Literature DB >> 3437313

Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment.

C D Ward, J Thompson, M D Humby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3437313      PMCID： PMC1032625          DOI： 10.1136/jnnp.50.12.1706

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine.

Authors:  J F Demonet; M Rostin; J M Dueymes; A Ioualalen; J L Montastruc; A Rascol
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

2.  Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease.

Authors: 
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

3.  Retroperitoneal fibrosis and bromocriptine.

Authors:  J V Bowler; I E Ormerod; N J Legg
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

4.  Retroperitoneal fibrosis revisited.

Authors:  M J Mitchinson
Journal:  Arch Pathol Lab Med       Date:  1986-09       Impact factor: 5.534
  4 in total
  2 in total

1.  Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology.

Authors:  C Alberti
Journal:  G Chir       Date:  2015 Jul-Aug

2.  Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine.

Authors:  A Herzog; H Minne; R Ziegler
Journal:  BMJ       Date:  1989-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.